For Blood and Money
Billionaires, Biotech, and the Quest for a Blockbuster Drug
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Acheter pour 37,53 $
Aucun mode de paiement valide enregistré.
Nous sommes désolés. Nous ne pouvons vendre ce titre avec ce mode de paiement
-
Narrateur(s):
-
Rob Shapiro
-
Auteur(s):
-
Nathan Vardi
À propos de cet audio
A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives.
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.
In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big.
What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses listeners in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction listen, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.
©2023 Nathan Vardi (P)2023 Audible, Inc.Vous pourriez aussi aimer...
-
Unscripted
- The Epic Battle for a Media Empire and the Redstone Family Legacy
- Auteur(s): James B. Stewart, Rachel Abrams
- Narrateur(s): Robert Petkoff
- Durée: 12 h et 23 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In 2016, the fate of Paramount Global’s entertainment empire hung precariously in the balance. Its founder and head, ninety-three-year-old Sumner M. Redstone, was facing a very public lawsuit brought by a former romantic companion, Manuela Herzer, which placed Sumner’s deteriorating health and questionable judgment under a harsh light.
-
-
Fascinating insight to rich people behaving badly.
- Écrit par Candice S. le 2023-06-20
Auteur(s): James B. Stewart, Autres
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- Auteur(s): Barry Werth
- Narrateur(s): Stephen Bowlby
- Durée: 18 h et 25 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
Auteur(s): Barry Werth
-
The Song of the Cell
- An Exploration of Medicine and the New Human
- Auteur(s): Siddhartha Mukherjee
- Narrateur(s): Dennis Boutsikaris
- Durée: 16 h et 3 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
From the author of The Emperor of All Maladies, winner of the Pulitzer Prize, and The Gene, a #1 New York Times bestseller, comes his most spectacular book yet, an exploration of medicine and our radical new ability to manipulate cells. Rich with Mukherjee’s revelatory and exhilarating stories of scientists, doctors, and the patients whose lives may be saved by their work, The Song of the Cell is the third book in this extraordinary writer’s exploration of what it means to be human.
-
-
Another success
- Écrit par afsaneh le 2023-06-16
Auteur(s): Siddhartha Mukherjee
-
Genentech
- The Beginnings of Biotech
- Auteur(s): Sally Smith Hughes
- Narrateur(s): Suzie Althens
- Durée: 7 h et 12 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.
Auteur(s): Sally Smith Hughes
-
Chip War
- The Quest to Dominate the World's Most Critical Technology
- Auteur(s): Chris Miller
- Narrateur(s): Stephen Graybill
- Durée: 12 h et 38 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
You may be surprised to learn that microchips are the new oil—the scarce resource on which the modern world depends. Today, military, economic, and geopolitical power are built on a foundation of computer chips. Virtually everything—from missiles to microwaves—runs on chips, including cars, smartphones, the stock market, even the electric grid. Until recently, America designed and built the fastest chips and maintained its lead as the #1 superpower, but America’s edge is in danger of slipping, undermined by players in Taiwan, Korea, and Europe taking over manufacturing.
-
-
Transistor, transistor, transistor.
- Écrit par Vitalii le 2022-11-30
Auteur(s): Chris Miller
-
The Antidote
- Inside the World of New Pharma
- Auteur(s): Barry Werth
- Narrateur(s): Sean Pratt
- Durée: 16 h et 27 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success.
Auteur(s): Barry Werth
-
Unscripted
- The Epic Battle for a Media Empire and the Redstone Family Legacy
- Auteur(s): James B. Stewart, Rachel Abrams
- Narrateur(s): Robert Petkoff
- Durée: 12 h et 23 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In 2016, the fate of Paramount Global’s entertainment empire hung precariously in the balance. Its founder and head, ninety-three-year-old Sumner M. Redstone, was facing a very public lawsuit brought by a former romantic companion, Manuela Herzer, which placed Sumner’s deteriorating health and questionable judgment under a harsh light.
-
-
Fascinating insight to rich people behaving badly.
- Écrit par Candice S. le 2023-06-20
Auteur(s): James B. Stewart, Autres
-
The Billion Dollar Molecule
- One Company's Quest for the Perfect Drug
- Auteur(s): Barry Werth
- Narrateur(s): Stephen Bowlby
- Durée: 18 h et 25 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.
Auteur(s): Barry Werth
-
The Song of the Cell
- An Exploration of Medicine and the New Human
- Auteur(s): Siddhartha Mukherjee
- Narrateur(s): Dennis Boutsikaris
- Durée: 16 h et 3 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
From the author of The Emperor of All Maladies, winner of the Pulitzer Prize, and The Gene, a #1 New York Times bestseller, comes his most spectacular book yet, an exploration of medicine and our radical new ability to manipulate cells. Rich with Mukherjee’s revelatory and exhilarating stories of scientists, doctors, and the patients whose lives may be saved by their work, The Song of the Cell is the third book in this extraordinary writer’s exploration of what it means to be human.
-
-
Another success
- Écrit par afsaneh le 2023-06-16
Auteur(s): Siddhartha Mukherjee
-
Genentech
- The Beginnings of Biotech
- Auteur(s): Sally Smith Hughes
- Narrateur(s): Suzie Althens
- Durée: 7 h et 12 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.
Auteur(s): Sally Smith Hughes
-
Chip War
- The Quest to Dominate the World's Most Critical Technology
- Auteur(s): Chris Miller
- Narrateur(s): Stephen Graybill
- Durée: 12 h et 38 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
You may be surprised to learn that microchips are the new oil—the scarce resource on which the modern world depends. Today, military, economic, and geopolitical power are built on a foundation of computer chips. Virtually everything—from missiles to microwaves—runs on chips, including cars, smartphones, the stock market, even the electric grid. Until recently, America designed and built the fastest chips and maintained its lead as the #1 superpower, but America’s edge is in danger of slipping, undermined by players in Taiwan, Korea, and Europe taking over manufacturing.
-
-
Transistor, transistor, transistor.
- Écrit par Vitalii le 2022-11-30
Auteur(s): Chris Miller
-
The Antidote
- Inside the World of New Pharma
- Auteur(s): Barry Werth
- Narrateur(s): Sean Pratt
- Durée: 16 h et 27 min
- Version intégrale
-
Au global
-
Performance
-
Histoire
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex's bold endurance and eventual success.
Auteur(s): Barry Werth